Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease

Journal of Neural Transmission

Volumn 118, Issue 5, 2011, Pages 747-752

  Lassmann, Hans ^a  

^a Medical University of Vienna   (Austria)

Author keywords

Alzheimer's disease; Inflammation; Mitochondria; Multiple sclerosis; Oxidative damage

Indexed keywords

3 NITROTYROSINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN RADICAL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; CELL DAMAGE; CONCURRENT INFECTION; DEMENTIA; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIPID OXIDATION; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; HUMANS; INFLAMMATION; MITOCHONDRIA; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 79956198149     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0607-8     Document Type: Review

References (67)

1. F Aboul-Enein H Rauschka B Kornek C Stadelmann A Stefferl W Brück CF Lucchinetti M Schmidbauer K Jellinger H Lassmann 2003 Preferential loss of myelin associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases J Neuropath Exp Neurol 62 25 33 12528815 1:CAS:528:DC%2BD3sXpsVKgtQ%3D%3D (Pubitemid 36068890)
2. AA Asuni A Boutajangout D Quartermain EM Sigurdsson 2007 Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements J Neurosci 27 9115 9129 17715348 10.1523/JNEUROSCI.2361-07.2007 1:CAS:528:DC%2BD2sXhtVSnsLbN (Pubitemid 47312068)
3. F Bard C Cannon R Barbour RL Burke D Games H Grajeda T Guido K Hu J Huang K Johnson-Wood K Khan D Kholodenko M Lee I Lieberburg R Motter M Nguyen F Soriano N Vasquez K Weiss B Welch P Seubert D Schenk T Yednock 2000 Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat Med 6 916 919 10932230 10.1038/78682 1:CAS:528:DC%2BD3cXlsFamtL4%3D (Pubitemid 30644751)
4. JP Bolanos A Almeida V Stewart S Peuchen JM Land JB Clark SJ Heales 1997 Nitric oxide mediated mitochondrial damage in the brain: Mechanisms and implication for neurdegenerative diseases J Neurochem 68 2227 2240 9166714 10.1046/j.1471-4159.1997.68062227.x 1:CAS:528:DyaK2sXjsVOgu7g%3D (Pubitemid 27218141)
5. A Boutajangout D Quartermain EM Sigurdsson 2010 Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model J Neurosci 30 16559 16561 21147995 10.1523/JNEUROSCI.4363-10.2010 1:CAS:528:DC%2BC3cXhsF2nurjI
6. AJ Bruce-Keller S Gupta TE Parrino AG Knight PJ Ebenezar AM Weidner H LeVine 3rd JN Keller WR Markesbery 2010 NOX activity is increased in mild cognitive impairment Antioxid Redox Signal 12 1371 1382 19929442 10.1089/ars.2009.2823 1:CAS:528:DC%2BC3cXls1WgurY%3D
7. W Brück Ph Porada S Poser P Rieckmann F Hanefeld HA Kretschmer H Lassmann 1995 Monocyte/macrophage differentiation in early multiple sclerosis Ann Neurol 38 788 796 7486871 10.1002/ana.410380514
8. DA Butterfield ML Bader Lange R Sultana 2010 Involvements oft he lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease Biochem Biophys Acta 1801 924 929 20176130 1:CAS:528: DC%2BC3cXntlagsL4%3D
9. Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H, Turnbull DM, Mahad DJ (2010) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol [epub ahead of print]
10. R Castellani K Hirai G Aliev KL Drew A Nunomura A Takeda AD Cash ME Obrenovich G Perry MA Smith 2002 Role of mitochondrial dysfunction in Alzheimer's disease J Neurosci Res 70 357 360 12391597 10.1002/jnr.10389 1:CAS:528:DC%2BD38XosVaqu78%3D (Pubitemid 35222373)
11. AH Cross PT Manning RM Keeling RE Schmidt TP Misko 1998 Peroxynitrite formation within the central nervous system in active multiple sclerosis J Neuroimmunol 88 45 56 9688323 10.1016/S0165-5728(98)00078-2 1:CAS:528: DyaK1cXktFGkurs%3D (Pubitemid 28342902)
12. A Dal Bianco M Bradl J Frischer A Kutzelnigg K Jellinger H Lassmann 2008 Multiple sclerosis and Alzheimer's disease Ann Neurol 63 2 174 183 17924575 10.1002/ana.21240 (Pubitemid 351355296)
13. SM De la Monte JR Wands 2006 Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease J Alzheimers Dis 9 167 181 (Pubitemid 44088244)
14. L Devi HK Anandatheerthavaranda 2010 Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases Biochem Biophys Acta 1801 11 19
15. M Di Filippo D Chasserini A Tozzi B Picconi P Calabresi 2010 Mitochondria and the link between neuroinflammation and neurodegeneration J Alzheimer's Disease 20 S369 S379
16. M Diaz-Sanchez K Williams GC DeLuca MM Esiri 2006 Protein co-expression with axonal injury in multiple sclerosis plaques Acta Neuropathol 111 289 299 16547760 10.1007/s00401-006-0045-0 1:CAS:528:DC%2BD28XjsFSmu7c%3D
17. R Dutta J McDonough X Yin J Peterson A Chang T Torres T Gudz WB Macklin DA Lewis RJ Fox R Rudick K Mirnics BD Trapp 2006 Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients Ann Neurol 59 478 489 16392116 10.1002/ana.20736 1:CAS:528:DC%2BD28XjtV2ltr4%3D (Pubitemid 43358068)
18. A Eckert KL Schulz V Rhein J Götz 2010 Convergence of amyloid-beta and tau pathologies on mitochondria in vivo Mol Neurobiol 41 107 114 20217279 10.1007/s12035-010-8109-5 1:CAS:528:DC%2BC3cXmsFSqtrk%3D
19. D Frenkel R Maron DS Burt HL Weiner 2005 Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease J Clin Invest 115 2423 2433 16100572 10.1172/JCI23241 1:CAS:528:DC%2BD2MXhtVSjsrfK (Pubitemid 41266204)
20. JM Frischer S Bramow A Dal Bianco CF Lucchinetti H Rauschka M Schmidbauer H Laursen PS Sorensen H Lassmann 2009 The relation between inflammation and neurodegeneration in multiple sclerosis brains Brain 132 1175 1189 19339255 10.1093/brain/awp070
21. KS Gandhi FC McKay M Cox C Riveros N Armstrong RN Head S Vucic DW Williams J Stankovich M Brown P Danoy GJ Stewart S Broadley P Moscato J Lechner-Scott RJ Scott DR Both ANZgene Multiple Sclerosis Genetics Consortium 2010 The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis Hum Mol Genet 19 2134 2143 20190274 10.1093/hmg/ddq090 1:CAS:528: DC%2BC3cXlvVWktro%3D
22. PS Giacomini PJ Darlington A Bar-Or 2009 Emerging multiple sclerosis disease-modifying therapies Curr Opin Neurol 22 226 232 19434781 10.1097/WCO.0b013e32832b4ca1 1:CAS:528:DC%2BD1MXlsVeqsLo%3D
23. B Hallgren P Sournader 1958 The effect of age on the non-haemin iron in the human brain J Neurochem 3 41 51 13611557 10.1111/j.1471-4159.1958.tb12607.x 1:CAS:528:DyaG1MXlslCluw%3D%3D
24. B Hallgren P Sournader 1960 The non haemin iron in the cerebral cortex in Alzheimer's disease J Neurochem 5 307 310 14399117 10.1111/j.1471-4159.1960. tb13369.x 1:CAS:528:DyaF3MXitlKrtg%3D%3D
25. GC Higgins PM Beart YS Shin MJ Chen NS Cheung P Nagley 2010 Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury J Alzheimer's disease 20 S453 S473
26. K Hirai G Aliev A Nunomura H Fujioka RL Russel CS Attwood AB Johnson Y Kress HV Vinters M Tabaton S Shimohama AD Cash SL Siedlak PL Harris PK Jones RB Petersen G Perry MA Smith 2001 Mitochondrial abnormalities in Alzheimer's disease J Neurosci 21 3017 3023 11312286 1:CAS:528:DC%2BD3MXjtFyqtbk%3D (Pubitemid 32323483)
27. S Hochmeister R Grundtner J Bauer B Engelhardt R Lyck G Gordon T Korosec A Kutzelnigg JJ Berger M Bradl RE Bittner H Lassmann 2006 Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis J Neuropathol Exp Neurol 65 855 865 16957579 10.1097/01.jnen.0000235119.52311.16 1:CAS:528:DC%2BD28XhtVGitrvN (Pubitemid 44371231)
28. C Holmes D Boche D Wilkinson G Yadegarfar V Hopkins A Bayer RW Jones R Bullock S Love JW Neal E Totova JA Nicoll 2008 Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controoed phase I trial Lancet 372 216 223 18640458 10.1016/S0140- 6736(08)61075-2 1:CAS:528:DC%2BD1cXoslWkt74%3D (Pubitemid 351978111)
29. C Holmes C Cunningham E Zotova J Woolford C Dean S Kerr D Culliford VH Perry 2009 Systemic inflammation and disease progression in Alzheimer disease Neurology 73 768 774 19738171 10.1212/WNL.0b013e3181b6bb95 1:STN:280: DC%2BD1MnhtFSjug%3D%3D
30. DM Holtzman 2008 Moving towards a vaccine Nature 454 418 420 18650906 10.1038/454418a 1:CAS:528:DC%2BD1cXovV2mtrs%3D
31. International Multiple Sclerosis Genetics Consortium (IMSGC) 2010 Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come Amer J Hum Genet 86 621 625 10.1016/j.ajhg.2010.02.027
32. K Jellinger 2006 Alzheimer 100-highlights in the history of Alzheimer research J Neural Transm 113 1603 1623 17039299 10.1007/s00702-006-0578-3 1:CAS:528:DC%2BD28XhtFegt7nK (Pubitemid 44660049)
33. K Jellinger W Paulus I Grundke-Iqbal P Riederer MB Youdim 1990 Brain iron and ferritin in Parkinson's and Alzheimer's diseases J Neural Trasnm 2 327 340 10.1007/BF02252926 1:CAS:528:DyaK3MXlsFKgtbg%3D
34. H Lassmann W Brück C Lucchinetti 2007 The immunopathology of multiple sclerosis: an overview Brain Pathol 17 210 218 17388952 10.1111/j.1750-3639.2007.00064.x (Pubitemid 46466140)
35. JSH Liu ML Zhao CF Brosnan SC Lee 2001 Expression of indicible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions Amer J Pathol 158 2057 2066 10.1016/S0002-9440(10)64677-9 1:CAS:528:DC%2BD3MXkvFyksb0%3D (Pubitemid 32545191)
36. D Mahad I Ziabreva H Lassmann D Turnbull 2008 Mitochondrial defects in acute multiple sclerosis lesions Brain 131 1722 1735 18515320 10.1093/brain/awn105 (Pubitemid 351957459)
37. D Mahad I Ziabreva G Campbell N Lax PS Hanson H Lassmann DH Turnbull 2009 Mitochondrial changes within axons in multiple sclerosis Brain 132 1161 1174 19293237 10.1093/brain/awp046
38. WR Markesbery MA Lovell 1998 Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiol Aging 19 33 36 9562500 10.1016/S0197-4580(98)00009-8 1:CAS:528:DyaK1cXisFyrtLg%3D (Pubitemid 28167792)
39. PL McGeer EG McGeer 2007 NSAIDs and Alzheimer disease: epidemiologicaö, animal model and clinical studies Neurobiol Aging 28 639 647 16697488 10.1016/j.neurobiolaging.2006.03.013 1:CAS:528:DC%2BD2sXislSrt74%3D (Pubitemid 46349357)
40. PL McGeer J Rogers EG McGeer 2006 Inflammation, anti-inflammatory agents and Alzheimer's disease: the last 12 years J Alzheimers Dis 9 3 Suppl 271 276 16914866 1:CAS:528:DC%2BD28XotFKktrc%3D (Pubitemid 44253320)
41. P Mecocci U MacGarvey MF Beal 1994 Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease Ann Neurol 36 747 751 7979220 10.1002/ana.410360510 1:STN:280:DyaK2M%2FmvF2nsA%3D%3D (Pubitemid 24337634)
42. KS Montine SJ Olson V Amarnath WO Whetsell DG Graham TJ Mintine 1997 Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4 Amer J Pathol 150 437 443 1:CAS:528:DyaK2sXhtlSgsbw%3D (Pubitemid 27073773)
43. KS Montine E Reich MD Neely KR Sidell SJ Olson WR Markesbery TJ Montine 1998 Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype J Neuropath Exp Neurol 57 415 425 9596412 10.1097/00005072-199805000-00005 1:CAS:528:DyaK1cXjsVWhtLw%3D (Pubitemid 28237325)
44. PI Moreira C Carvalho X Zhu MA Smith G Perry 2010 Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology Biochem Biophys Acta 1802 2 10 19853658 1:CAS:528:DC%2BD1MXhsFanurnO
45. JA Nicoll D Wilkinson C Holmes P Steart H Marham RO Weller 2003 Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report Nat Med 9 448 452 12640446 10.1038/nm840 1:CAS:528:DC%2BD3sXisVOmu78%3D (Pubitemid 36460079)
46. A Nunomura G Perry G Aliev K Hirai A Takeda EK Balraj PK Jones H Ghanbari T Wataya S Shimohama S Chiba CS Atwood RB Petersen MA Smith 2001 Oxidative damage is the earliest event in Alzheimer disease J Neuropath Exp Neurol 60 759 767 11487050 1:CAS:528:DC%2BD3MXmtVGmsr0%3D (Pubitemid 32678256)
47. A Nunomura S Chiba CF Lippa P Cras RN Kalaria A Takeda K Honda MA Smith G Perry 2004 Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease Neurobiol Dis 17 108 113 15350971 10.1016/j.nbd.2004.06.003 1:CAS:528:DC%2BD2cXntlaqsr8%3D (Pubitemid 39209318)
48. A Nunomura T Hofer PI Moreira RJ Castellani MA Smith G Perry 2009 RNA oxidation in Alzheimer disease and related neurodegenerative disorders Acta Neuropathol 118 151 166 19271225 10.1007/s00401-009-0508-1 1:CAS:528: DC%2BD1MXmt1agsr4%3D
49. G Perry LM Sayre CS Atwood RJ Castellani AD Cash CA Rottkamp MA Smith 2002 The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications CNS Drugs 16 339 352 11994023 10.2165/00023210-200216050-00006 1:CAS:528:DC%2BD38Xks1Omtr0%3D (Pubitemid 34548201)
50. VH Perry JA Nicoll C Holmes 2010 Microglia in neurodegenerative disease Nat Rev Neurol 6 193 201 20234358 10.1038/nrneurol.2010.17
51. TT Reed WM Pierce WR Markesbery DA Butterfield 2009 Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD Brain Res 1274 66 76 19374891 10.1016/j.brainres.2009.04.009 1:CAS:528:DC%2BD1MXmtlOqsb8%3D
52. V Rhein X Song A Wiesner LM Ittner G Baysang F Meier L Ozmen H Bluethmann U Dröse E Savaskan C Czech J Götz A Eckert 2009 Amyloid.beta and tau synergistically impair the oxidative phosphorylation system in tripple transgenic Alzheimer's disease mice Proc Natl Acad Sci USA 106 20057 20062 19897719 1:CAS:528:DC%2BD1MXhsFGjtLvE
53. H Rosenmann N Grigoriadis D Karussis M Boimel O Touloumi H Ovaida O Abramsky 2006 Taupopathy-like abnormalities and neurological deficits in mice immunized with neuronal tau protein Arch Neurol 63 1459 1467 17030663 10.1001/archneur.63.10.1459 (Pubitemid 44547559)
54. D Schenk R Barbour W Dunn G Gordon H Grajeda T Guido K Hu J Huang K Johnson-Wood K Khan D Kholodenlko M Lee Z Liao I Lieberburg R Motter L Mutter F Soriano G Shopp N Vasquez C Vandevert S Walker M Wogulis T Yednock D Games P Seubert 1999 Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 173 177 10408445 10.1038/22124 1:CAS:528:DyaK1MXks1Khsbc%3D (Pubitemid 29327547)
55. R Sharma MT Fischer J Bauer PA Felts KJ Smith T Misu K Fujihara M Bradl H Lassmann 2010 Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination Acta Neuropathol 120 2 223 236 20532539 10.1007/s00401-010-0704-z 1:CAS:528:DC%2BC3cXotVKnsLc%3D
56. S Shimohama H Tanino N Kawakami N Okamura Y Kodama T Yamaguchi T Hayakawa A Nunomura S Chiba G Perry MA Smith S Fujimoto 2000 Activation of NADPH oxidase in Alzheimer's disease brains Biochem Biophys Res Commun 273 5 9 10873554 10.1006/bbrc.2000.2897 1:CAS:528:DC%2BD3cXkt1Knurs%3D (Pubitemid 30426853)
57. JM Te Koppele PJ Lucassen AN Sakkee JG Van Asten R Ravid DF Swaab CF Van Bezooijen 1996 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease Neurobiol Aging 17 819 826 9363791 10.1016/S0197-4580(96) 00165-0 1:CAS:528:DyaK2sXjt1yksg%3D%3D (Pubitemid 27022733)
58. T Togo H Akiyama E Iseki H Kondo K Ikeda M Kato T Oda K Tsuchiya K Kosaka 2002 Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases J Neuroimmunol 124 83 92 11958825 10.1016/S0165-5728(01) 00496-9 1:CAS:528:DC%2BD38XhslWjtbc%3D (Pubitemid 34212013)
59. BD Trapp KA Nave 2008 Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31 247 269 18558855 10.1146/annurev.neuro.30.051606. 094313 1:CAS:528:DC%2BD1cXpt12nsrY%3D
60. B Trapp P Stys 2009 Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis Lancet Neurology 8 80 291 10.1016/S1474-4422(09) 70043-2
61. J Van Horssen G Schreibelt J Drexhage T Hazes CD Dijkstra P van der Valk HE de Vires 2008 Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression Free Radical Biol Med 45 1729 1737 10.1016/j.freeradbiomed.2008.09.023
62. J Van Horssen ME Witte G Schreibelt HE de Vries 2011 Radical changes in multiple sclerosis pathogenesis Biochem Biophys Acta 1812 141 150 20600869
63. S Veto P Acs J Bauer H Lassmann Z Berente G Setalo Jr G Borgulya B Sumegi S Komoly F Gallyas Jr Z Illes 2010 Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death Brain 133 822 834 20157013 10.1093/brain/awp337
64. H Wiendl R Hohlfeld 2009 Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes Neurology 72 1008 1015 19289741 10.1212/01.wnl.0000344417.42972.54 1:CAS:528:DC%2BD1MXivVemsbw%3D
65. BL Wilkinson GE Landreth 2006 The microglial NADPH oxidase complex of oxidative stress in Alzheimer's disease J Neuroinflammation 3 30 17094809 10.1186/1742-2094-3-30 (Pubitemid 44774182)
66. ME Witte JJ Geurts HE de Vires P van der Valk J van Horssen 2010 Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration Mitochondrion 10 411 418 20573557 10.1016/j.mito.2010.05.014 1:CAS:528:DC%2BC3cXpvFOnt7o%3D
67. I Ziabreva G Campbell J Rist J Zambonin J Rorbach MM Wydro H Lassmann RJ Franklin D Mahad 2010 Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes Glia 58 1827 1837 20665559 10.1002/glia.21052